Latin America Digital PCR and Real Time PCR (qPCR) Market

Latin America Digital PCR and Real-Time PCR Market Size (2024 to 2029)

The Latin America Digital PCR and Real-Time PCR (qPCR) market accounted for USD 581.42 million in 2024. It is expected to grow at 8.88% and is predicted to be around USD 889.67 million in 2029.

Factors driving the growth of the Digital Polymerase Chain Reaction (PCR) and real-time PCR market include the increasing prevalence of infectious diseases and the growing awareness and acceptance of personalized drugs. Moreover, technological advancements are expected to drive market growth during the forecast period. In addition, other factors such as the growth of the geriatric population, the increasing incidence of genetic disorders in the field of PCR, and the increase in investment and availability of funds for research based on PCR stimulate the growth of dPCR and qPCR across Latin America.

The need for highly sensitive molecular diagnostics is expected to dramatically reduce false-negative reverse transcription PCR (RT-PCR) results, which is a significant clinical need for a robust diagnostic tool for detecting COVID-19 due to the global pandemic. Since the COVID-19 pandemic, significant pro-dPCR research has been published on qPCR for COVID-19 testing. There has been a significant increase in demand for dPCR systems and SARS-CoV-2 kits due to several factors such as increased sensitivity of digital droplet PCR (ddPCR), lack of inhibition of sample types, and ease of understanding the results. In addition, several companies have obtained emergency use authorization from the United States Food and Drug Administration (FDA) for their dPCR test kits to meet the mandatory requirement of diagnostic testing for COVID- 19 due to increased demand.

Clinical and research uses are expected to drive the market demand for dPCR and qPCR. This is due to the trend of government and non-government organizations to research this sector and the funds they provide, and the range of clinical applications such as blood work, cancer testing, and other disease diagnostics.

The increased funding for R&D activities should offer potential growth opportunities to market players. For example, to discover the drug or biomarker of these viral diseases, researchers are widely adopting digital PCR. Likewise, advances in digital PCR techniques hold great promise for the detection of rare cancer biomarkers. For example, researchers should use ddPCR in conjunction with molecular biology techniques to discover new cancer biomarkers. Therefore, an increasing progression and prevalence of diseases offer enormous potential for the adoption of PCR techniques.

However, the high costs of the instruments, especially dPCR, and the technical limitations of PCR limit the market's growth. In addition, the skills associated with PCR are unavailable, and the delay in getting raw materials because of the travel ban due to covid is expected to challenge the growth of this market.

This research report on the Latin America Digital PCR and Real-Time PCR Market has been segmented and sub-segmented into the following categories.

Latin America Digital PCR and Real-Time PCR Market Analysis By Product

• Consumables
• Reagents and Instruments

Latin America Digital PCR and Real-Time PCR Market Analysis By Technology

• Quantitative PCR
• Digital PCR

Latin America Digital PCR and Real-Time PCR Market Analysis By Application

• Tumors
• Blood Testing
• Pathogen Detection
• Research & Forensics

Latin America Digital PCR and Real-Time PCR Market Analysis By End User 

• Hospitals
• Research & Forensic Centers
• Pharmaceutical & Bio-Technological Firms
• Academic Institutions

Latin America Digital PCR and Real-Time PCR Market Analysis By Country

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America

Geographically, Brazil is expected to be the largest market due to increasing funding for qPCR and dPCR technologies, increasing incidence and prevalence of infectious and genetic diseases, the continued reduction in the cost of gene sequencing, and the presence of companies in the region.

However, Argentina is expected to grow at a faster CAGR due to rapidly developing economies, aging population growth coupled with increased incidence of genetic diseases, the growing outsourcing of clinical trials and research to the region, and the growing number of CROs.

KEY MARKET PLAYERS

The major key players in the market are Thermo Fisher Scientific Inc., F Hoffman-La Roche Ltd., Bio-Rad Laboratories, Qiagen N.V., Taraka Bio Inc., Affymetrix Inc., Agilent Technologies Inc., Fluidigm Corporation, Danaher Corporation, and Becton & Dickson Company.